CT-derived vertebral bone mineral density is a useful biomarker to predict COVID-19 outcome
Bone · 2024
DOI: 10.1016/j.bone.2024.117095 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Bone, 2024. Verfasst von Shuhei Azekawa und 32 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary Medicine, Department of Medicine, Keio University, School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: COVID-19, Bone Density, Tomography, X-Ray Computed, SARS-CoV-2. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development, Core Research for Evolutional Science and Technology, Ministry of Health, Labour and Welfare.
Abstract (Originalsprache)
The low vertebral bone computed tomography (CT) Hounsfield unit values measured on CT scans reflect low bone mineral density (BMD) and are known as diagnostic indicators for osteoporosis. The potential prognostic significance of low BMD defined by vertebral bone CT values for the coronavirus disease 2019 (COVID-19) remains unclear. This study aimed to assess the impact of BMD on the clinical outcome in Japanese patients with COVID-19 and evaluate the association between BMD and critical outcomes, such as high-flow nasal cannula, non-invasive and invasive positive pressure ventilation, extracorporeal membrane oxygenation, or death. We examined the effects of COVID-19 severity on the change of BMD over time. This multicenter retrospective cohort study enrolled 1132 inpatients with COVID-19 from the Japan COVID-19 Task Force database between February 2020 and September 2022. The bone CT values of the 4th, 7th, and 10th thoracic vertebrae were measured from chest CT images. The average of these values was defined as BMD. Furthermore, a comparative analysis was conducted between the BMD on admission and its value 3 months later. The low BMD group had a higher proportion of critical outcomes than did the high BMD group. In a subanalysis stratifying patients by epidemic wave according to onset time, critical outcomes were higher in the low BMD group in the 1st-4th waves. Multivariable logistic analysis of previously reported factors associated with COVID-19 severity revealed that low BMD, chronic kidney disease, and diabetes were independently associated with critical outcomes. At 3 months post-infection, patients with oxygen demand during hospitalization showed markedly decreased BMD than did those on admission. Low BMD in patients with COVID-19 may help predict severe disease after the disease onset. BMD may decrease over time in patients with severe COVID-19, and the impact on sequelae symptoms should be investigated in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pulmonary Medicine, Department of Medicine, Keio University, School of Medicine, Tokyo, Japan.
- Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
- Division of Pulmonary Medicine, Department of Medicine, Keio University, School of Medicine, Tokyo, Japan. Electronic address: bachibachi472000@z6.keio.jp.
- Division of Pulmonary Medicine, Department of Medicine, Keio University, School of Medicine, Tokyo, Japan; Department of Clinical Medicine (Laboratory of Bioregulatory Medicine), Kitasato University School of Pharmacy,…
- Division of Pulmonary Medicine, Department of Medicine, Keio University, School of Medicine, Tokyo, Japan; Department of Infectious Diseases, Keio University School of Medicine, Tokyo, Japan.
- Internal Medicine, JCHO (Japan Community Health Care Organization) Saitama Medical Center, Saitama, Japan.
Förderung
- Japan Agency for Medical Research and Development
- Core Research for Evolutional Science and Technology
- Ministry of Health, Labour and Welfare
- Keio University School of Medicine Graduate School of Medicine
- Precursory Research for Embryonic Science and Technology
Zitieren
APA
Azekawa, S., Maetani, T., Chubachi, S., Asakura, T., Tanabe, N., Shiraishi, Y., Namkoong, H., Tanaka, H., Shimada, T., Fukushima, T., Otake, S., Nakagawara, K., Watase, M., Terai, H., Sasaki, M., Ueda, S., Kato, Y., Harada, N., Suzuki, S., …, & Fukunaga, K. (2024). CT-derived vertebral bone mineral density is a useful biomarker to predict COVID-19 outcome. Bone. https://doi.org/10.1016/j.bone.2024.117095
Vancouver
Azekawa S, Maetani T, Chubachi S, Asakura T, Tanabe N, Shiraishi Y, et al. CT-derived vertebral bone mineral density is a useful biomarker to predict COVID-19 outcome. Bone. 2024. doi:10.1016/j.bone.2024.117095
BibTeX
@article{Azekawa2024,
author = {Azekawa, Shuhei and Maetani, Tomoki and Chubachi, Shotaro and Asakura, Takanori and Tanabe, Naoya and Shiraishi, Yusuke and Namkoong, Ho and Tanaka, Hiromu and Shimada, Takashi and Fukushima, Takahiro and Otake, Shiro and Nakagawara, Kensuke and Watase, Mayuko and Terai, Hideki and Sasaki, Mamoru and Ueda, Soichiro and Kato, Yukari and Harada, Norihiro and Suzuki, Shoji and Yoshida, Shuichi and Tateno, Hiroki and Yamada, Yoshitake and Jinzaki, Masahiro and Hirai, Toyohiro and Okada, Yukinori and Koike, Ryuji and Ishii, Makoto and Kimura, Akinori and Imoto, Seiya and Miyano, Satoru and Ogawa, Seishi and Kanai, Takanori and Fukunaga, Koichi},
title = {CT-derived vertebral bone mineral density is a useful biomarker to predict COVID-19 outcome},
journal = {Bone},
year = {2024},
doi = {10.1016/j.bone.2024.117095}
}
EUVIMED